FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 21

Author

Admin 422 posts 0 comments

Articles

Industry Leaders Pioneering Transformation in Insurance Software

Admin Jun 11, 2025
The insurance industry is undergoing a significant transformation, driven by advancements in technology and…
Featured News

Western Alliance Bank Donates $100K for Wildfire Relief

Admin Jun 10, 2025
Western Alliance Bank has announced a generous donation of $100,000 to the American Red Cross to assist…
Whitepaper

Building a Better Banking Ecosystem with Modern Network Connectivity

Admin Jun 9, 2025
The technology infrastructure most businesses rely on is rapidly transforming, with the cloud and AI-driven…
Whitepaper

The future of financial services: better customer experiences start with…

Admin Jun 6, 2025
Over the last few years, consumers have shown extraordinary resilience through much uncertainty. Many have adapted…
Featured News

Keep Financial Launches New Compensation Platform to Attract Top Talent and…

Admin Jun 5, 2025
In a bold move to redefine employee compensation, Keep Financial has announced the launch of its cutting-edge…
Featured News

The Future of Embedded Finance: APIs Leading the Way

Admin Jun 4, 2025
In a fast-evolving digital economy, embedded finance is emerging as one of the most transformative forces…
Webinar

Progress and Challenges to Achieving a Common Taxonomy for Climate Investments

Admin Jun 3, 2025
As countries and governments have pursued policies and regulations to fulfill their commitments to achieve a…
Whitepaper

The Money Revolution Crypto, CBDCs, and the future of finance

Admin Jun 2, 2025
Money has transformed human society, enabling commerce and trade even between widely dispersed geographic…
Featured News

Economic Growth, RBI Reforms, and Strategic Investments

Admin May 30, 2025
India's Q4 FY25 GDP Growth Surpasses Expectations India's economy grew by 7.4% in the January–March 2025…
Articles

The FinTech Revolution: How Technology Is Reshaping Financial Services 

Admin May 29, 2025
The financial world is undergoing a transformative shift powered by digital innovation. What was once a…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
    2026-05-14T05:30:00Z
    PARIS, FRANCE, 14 May 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of the Phase II LANTIC trial for the first aesthetic glabellar lines indication with corabotase, a custom-designed molecule recognized as the first in...


    Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
    2026-05-14T03:21:29Z
    SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical Co., Ltd. (“Tenry...


    Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
    2026-05-14T02:00:00Z
    MELBOURNE, Australia , May 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including...


    Memopezil Under Investigation: Evaluating the Claims, Risks and Hidden Official Website Complaints about the Natural Donepezil Cocoa and Honey Protocol
    2026-05-14T01:09:43Z
    Bacopa Monnieri, Rhodiola Rosea, L-Theanine, and Panax Ginseng in Memopezil Supplement Facts, Refund Policy, Ingredients, and Cognitive Support Claims Explained


    JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies
    2026-05-14T00:21:29Z
    JellyTide Scam or Legit? BHB Salts, Apple Cider Vinegar Gummies, Side Effects, Dosage, and 60-Day Guarantee Explained


    Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men
    2026-05-13T22:20:56Z
    Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched


    Venus Concept Announces Senior Management Changes
    2026-05-13T21:25:00Z
    TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced changes to its senior leadership team.


    Management team’s 2025 market-based Options have vested
    2026-05-13T21:00:00Z
    Share price increase from $6 to $30 triggers full vesting


    Aptose Reports First Quarter 2026 Results 
    2026-05-13T21:00:00Z
    SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib...


    ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:55:00Z
    LIGHTHOUSE POINT, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (OTCQB: ZVSA), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of inflammatory and renal diseases...


    Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:35:00Z
    - Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use...


    Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
    2026-05-13T20:30:00Z
    Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET


    Park Dental Partners Announces First Quarter 2026 Results
    2026-05-13T20:30:00Z
    MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter...


    Combined General Meeting of June 3, 2026
    2026-05-13T20:30:00Z
    Châtillon, France, May 13, 2026


    EDAP | Focal One to Host Investor Day on June 1, 2026
    2026-05-13T20:30:00Z
    AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will host an Investor Day for...


    Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
    2026-05-13T20:25:58Z
    LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the...


    Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
    2026-05-13T20:07:25Z
    First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026


    Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human...


    SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
    2026-05-13T20:05:00Z
    Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue


    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    2026-05-13T20:05:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach...


    Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026


    Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
    2026-05-13T20:05:00Z
    JUPITER, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...


    Bionano Reports First Quarter 2026 Results and Provides a Business Update
    2026-05-13T20:05:00Z
    Conference call today, May 13, 2026, at 4:30 PM ET


    LogicMark, Inc. Announces Strong First Quarter 2026 Results
    2026-05-13T20:05:00Z
    Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows


    IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
    2026-05-13T20:05:00Z
    NASHVILLE, Tenn., May 13, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its first quarter results:


    Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:05:00Z
    100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study


    Glass House Brands Reports First Quarter 2026 Financial Results
    2026-05-13T20:05:00Z
    LONG BEACH, Calif. and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF),...


    Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
    2026-05-13T20:05:00Z
    REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial...


    Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with...


    Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    MIAMI, May 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.